...
首页> 外文期刊>Biotechnology Law Report >Patenting of Stem Cells and Processes Involving Stem Cells According to the Rules of the European Patent Convention
【24h】

Patenting of Stem Cells and Processes Involving Stem Cells According to the Rules of the European Patent Convention

机译:根据欧洲专利公约的规则对干细胞和涉及干细胞的工艺进行专利授权

获取原文
获取原文并翻译 | 示例
           

摘要

STEM CELLS ARE UNDIFFERBNTIATED CELLS that Can divide over a long period of time regardless of their origin and therefore can self-renew, without thereby differentiating, but can also differentiate into specialized cells after appropriate stimulation, On the basis of these properties, it is hoped that sooner or later, it will be possible to use human stem cells for treatment of diseases caused by defective or inadequate functioning of certain cells. The best-known examples of such diseases are Parkin son's, juvenile diabetes, and myocardial diseases. In 2001, The Han-delsblatt had estimated the economic potential of human stem cells at US360 billion dollar. Because more potential fields of use continue to be added; for example, screening and testing of active substances, the actual economic potential is probably now far higher.
机译:干细胞是未分化的细胞,无论其来源如何都可以长时间分裂,因此可以自我更新,而不会因此分化,但在适当刺激后也可以分化为特化细胞。基于这些特性,希望这样一来,就有可能将人类干细胞用于治疗某些细胞功能缺陷或不足引起的疾病。这种疾病的最著名例子是帕金森氏病,青少年糖尿病和心肌病。 2001年,Han-delsblatt估计人类干细胞的经济潜力为3600亿美元。因为继续增加了更多潜在的使用领域;例如,对活性物质进行筛选和测试,现在的实际经济潜力可能要高得多。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号